SIRT1 and breast carcinoma: Previous work with these two compounds in combination on MDA-MB-157 and HCC1806 breast cancer cells have shown them to affect the activity of SIRT1; therefore, we investigated the effects of compounds on HDAC and HAT enzyme activities in the current study.